Cargando…

The development of an antimicrobial EVD catheter to protect against multi-resistant hospital “superbugs”

Detalles Bibliográficos
Autores principales:	Ashraf, Waheed, Bayston, Roger, Stevenson, Oxana
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3026525/ http://dx.doi.org/10.1186/1743-8454-7-S1-S46

Ejemplares similares

An in vitro study to evaluate the antimicrobial activity of a shunt catheter against Propionibacterium acnes
por: Ashraf, Waheed, et al.
Publicado: (2009)

An in vitro investigation of the antimicrobial activity of silver-processed catheters for external ventricular drainage
por: Vera, Litza, et al.
Publicado: (2009)

Burden for the infection control programme of a European hospital of getting prepared and treat a patient (PT) with Ebola virus disease (EVD)
por: Iten, A, et al.
Publicado: (2015)

Identifying infection prevention and control gaps in healthcare facilities operating in Rivers state during the EVD outbreak in Nigeria 2014
por: Okwor, TJ, et al.
Publicado: (2015)

A survey of people with ventriculoatrial shunts in the community
por: Bayston, Roger, et al.
Publicado: (2006)

Baseline evaluation of infection prevention and control (IPC) in the context of Ebola virus disease (EVD) in nine healthcare facilities in the city of Conakry, Guinea
por: Diallo, A, et al.
Publicado: (2015)

The use of ASET (Anti Staph Epidermidis Titre) in the diagnosis of ventriculo-atrial shunt infection
por: Reaper, Jacqueline, et al.
Publicado: (2010)

Analysis of twenty-four "failures" of Bactiseal™ antimicrobial shunts reported to FDA
por: Bayston, Roger
Publicado: (2006)

Indian superbug: analysis of laypress reports
por: Jeyaseelan Senthinath, T, et al.
Publicado: (2011)

Do bactisealventriculostomy catheters have a low rate of ventriculitis and catheter colonization in clinical practice?
por: Strachan, Roger, et al.
Publicado: (2010)

Superheroes Against Superbugs (SaS)
Publicado: (2020)

Intrinsic Antimicrobial Resistance Determinants in the Superbug Pseudomonas aeruginosa
por: Murray, Justine L., et al.
Publicado: (2015)

Characterization of Ebola Virus Disease (EVD) in Rhesus Monkeys for Development of EVD Therapeutics
por: Warren, Travis, et al.
Publicado: (2020)

Silicon versus Superbug: Assessing Machine Learning’s Role in the Fight against Antimicrobial Resistance
por: Coxe, Tallon, et al.
Publicado: (2023)

An external ventricular drainage catheter impregnated with rifampicin, trimethoprim and triclosan, with extended activity against MDR Gram-negative bacteria: an in vitro and in vivo study
por: Bayston, Roger, et al.
Publicado: (2019)

Multitarget Approaches against Multiresistant Superbugs
por: Gray, Declan Alan, et al.
Publicado: (2020)

The other superbugs
por: Fleming, Nic
Publicado: (2021)

Fitness of use of Biopatch® and Tegaderm(TM) CHG for protecting central venous catheters and arterial lines in critically ill patients
por: Eggimann, P, et al.
Publicado: (2015)

Epidemiology of ebolavirus disease (EVD) and occupational EVD in health care workers in Sub-Saharan Africa: Need for strengthened public health preparedness
por: Ngatu, Nlandu Roger, et al.
Publicado: (2017)

The Political Economy of the Ebola Virus Disease (EVD); Taking Individual and Community Ownership in the Prevention and Control of EVD
por: Obilade, Titilola T.
Publicado: (2015)

O083: Prohibit (preventing hospital-acquired infections by intervention and training): preliminary results of a European multi-center study on the effectiveness of a hand hygiene campaign and a central venous catheter bundle
por: van der Kooi, T, et al.
Publicado: (2013)

Nanoantibiotics: strategic assets in the fight against drug-resistant superbugs
por: Khurana, Chandni, et al.
Publicado: (2018)

Lumbo-peritoneal shunting for idiopathic intracranial hypertension: what is the optimum catheter length and placement to avoid low-pressure headaches?
por: Strachan, Roger, et al.
Publicado: (2006)

Clinical and antimicrobial profile of Acinetobacter spp.: An emerging nosocomial superbug
por: Tripathi, Purti C., et al.
Publicado: (2014)

The Potential of Modified and Multimeric Antimicrobial Peptide Materials as Superbug Killers
por: Matthyssen, Tamara, et al.
Publicado: (2022)

Introducing Ebola (EVD): An Unnecessary Surprise
por: Bindenagel Šehović, Annamarie
Publicado: (2017)

Nitric Oxide-Releasing Chitosan for the Treatment of Multi-Drug Resistant Superbugs
por: Kougoulos, Terry, et al.
Publicado: (2017)

Balancing the Virulence and Antimicrobial Resistance in VISA DAP-R CA-MRSA Superbug
por: Salemi, Rossella, et al.
Publicado: (2022)

P012 Antibiofilm activity of staphylococcal peptide derivative(s) against Candida auris biofilms in vitro and in an animal model of catheter-associated infection
por: Kumari, Anjna, et al.
Publicado: (2022)

Can the application of the international health regulations to antimicrobial resistance events help to preserve antimicrobials?
por: Wernli, D, et al.
Publicado: (2011)

Phages against killer superbugs: An enticing strategy against antibiotics-resistant pathogens
por: Baral, Bikash
Publicado: (2023)

Death from pan-resistant superbug
por: Nichols, Larry
Publicado: (2019)

Antibody mediated protection of immunized macaques against pathogenic SHIV challenge
por: Srivastava, Indresh K, et al.
Publicado: (2006)

Can body appreciation protect against media-induced body dissatisfaction?
por: Andrew, Rachel, et al.
Publicado: (2015)

Molecular approaches to understanding pregnancy-induced protection against breast cancer
por: Blakely, CM, et al.
Publicado: (2005)

P070 Antimicrobial peptides from the Coleoptera family Scarabaeidae against Candida and Cryptococcus pathogenic yeasts.
por: Toro, Lily J., et al.
Publicado: (2022)

P002 Antifungal activity of antimicrobial synthetic peptides against Candida species of public health importance
por: Torres, Richar, et al.
Publicado: (2022)

O011: Reduction of resistance by sublingual administration of antimicrobials
por: Catry, B, et al.
Publicado: (2013)

Protecting intellectual property associated with health technology trials – another barrier to multi-centre trials?
por: Ross, Sue, et al.
Publicado: (2011)

OA02.05. Antimicrobial activity of Rasamanikya against different pathogenic microbes w.s.r. to skin disease
por: Kumari, Poonam, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_iokpr106r1opikm5bo9s01a3n3